Syntenin signaling lead to increases in MMP2 expression in melanoma and glioblastoma [14,52], indicating that syntenin can induce tumor cell invasion through the expression of matrix-metalloprotease (MMP) 2 (Figure 3A). This evidence concerns the gene SDCBP and melanoma.